Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Revista De Gastroenterologia De Mexico|October 28, 2009
[Mexican consensus on the use of agents anti-TNF-alpha in the treatment of inflammatory bowel disease.]J K Yamamoto-Furusho, F Bosques-Padilla,
Revista De Gastroenterologia De Mexico (English)|November 19, 2021
Real-world experience with MMX mesalazine use in Mexican patients with ulcerative colitis at two tertiary care centersJ K Yamamoto-Furusho, N N Parra-Holguín
Revista De Gastroenterologia De Mexico (English)|June 20, 2021
Real-world experience with MMX mesalazine use in Mexican patients with ulcerative colitis at two tertiary care centersJ K Yamamoto-Furusho, N N Parra-Holguín
European Annals of Allergy and Clinical Immunology|October 10, 2019
Drug allergy is associated with the development of extraintestinal manifestations in patients with ulcerative colitisJ J Toledo-Maurino, J K Yamamoto-Furusho
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|August 14, 2009
HLA-DRB1 alleles are associated with the clinical course of disease and steroid dependence in Mexican patients with ulcerative colitisJ K Yamamoto-Furusho, L Rodríguez-Bores, J Granados
Revista De Gastroenterologia De Mexico|April 29, 2010
[Oral cyclosporine microemulsion for the treatment of severe chronic idiopathic ulcerative colitis refractory to intravenous steroids: experience in two cases.]E Coss-Adame, J Barahona-Garrido, J K Yamamoto-Furusho
Revista De Gastroenterologia De Mexico|November 20, 2012
[Infection frequency in patients with chronic idiopathic ulcerative colitis]J K Yamamoto-Furusho, J L de León-Rendón, L Rodas
Mycopathologia|January 1, 1997
Immunologic, genetic and social human risk factors associated to histoplasmosis: studies in the State of Guerrero, MexicoM L Taylor, A Pérez-Mejía, J K Yamamoto-Furusho, et al.
Revista De Gastroenterologia De Mexico (English)|December 15, 2020
Second Mexican consensus on biologic therapy and small-molecule inhibitors in inflammatory bowel diseaseJ K Yamamoto-Furusho, F J Bosques-Padilla, M A Martínez-Vázquez, et al.
Clinical and Experimental Immunology|February 18, 2014
Expression of interleukin (IL)-19 and IL-24 in inflammatory bowel disease patients: a cross-sectional studyG Fonseca-Camarillo, J Furuzawa-Carballeda, J Granados, et al.
Pageof 5